91 results on '"Rubinsteyn, Alex"'
Search Results
2. How fast can we make interpreted Python?
3. Locality Optimization for Data Parallel Programs
4. ACE configurator for ELISpot: optimizing combinatorial design of pooled ELISpot assays with an epitope similarity model
5. ACE Configurator for ELISpot (ACE): Optimizing Combinatorial Design of Pooled ELISpot Assays with an Epitope Similarity Model
6. OpenVax: An Open-Source Computational Pipeline for Cancer Neoantigen Prediction
7. High-Throughput MHC I Ligand Prediction Using MHCflurry
8. Atezolizumab plus personalized neoantigen vaccination (PGV001) in patients with urothelial cancer.
9. ACE configurator for ELISpot: optimizing combinatorial design of pooled ELISpot assays with an epitope similarity model.
10. Bioinformatic methods for cancer neoantigen prediction
11. LENS: Landscape of Effective Neoantigens Software
12. Abstract CT270: Immunogenicity of PGV_001 neoantigen vaccine in a Phase-I clinical trial, across various types of cancers in adjuvant setting
13. Comparing Long Read Fusion Callers using Simulated Read Data
14. LENS: Landscape of Effective Neoantigens Software
15. Abstract LB048: An adjuvant personalized neoantigen peptide vaccine for the treatment of malignancies (PGV-001)
16. Additional file 1 of Landscape and selection of vaccine epitopes in SARS-CoV-2
17. A model of antigen processing improves prediction of MHC I-presented peptides
18. Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction
19. 289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting
20. CTIM-17. PHASE I STUDY OF THE SAFETY AND IMMUNOGENICITY OF PERSONALIZED NEOANTIGEN VACCINES AND TUMOR TREATING FIELDS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
21. EPCO-22. IDENTIFYING NEOANTIGENS FOR A PERSONALIZED MUTATION-DERIVED GENOMIC VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
22. MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing
23. Abstract CT173: PGV-001: A phase I trial of a multipeptide personalized neoantigen vaccine in the adjuvant setting
24. Landscape and Selection of Vaccine Epitopes in SARS-CoV-2
25. A model of antigen processing improves prediction of MHC I-presented peptides
26. Abstract B23: Enhanced HLA-II epitope prediction for immunotherapy with novel proteomics and genomics approaches
27. Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction
28. Abstract CT062: A Phase I study of the safety and immunogenicity of personalized mutation-derived tumor vaccine and treatment fields in patients with newly diagnosed glioblastoma
29. Abstract CT096: Phase I study of in situ autologous vaccination for prostate cancer in a neo-adjuvant setting
30. A phase I study of the safety and immunogenicity of a multi-peptide personalized genomic vaccine in the adjuvant treatment of solid tumors and hematological malignancies.
31. Abstract A005: A phase I study of the safety and immunogenicity of a multipeptide personalized genomic vaccine in the adjuvant treatment of solid cancers
32. Abstract B079: Evaluation of tools for predicting mutated tumor antigens from exome and RNA sequencing
33. Abstract B080: Improved neoantigen vaccine selection by combining prediction of pMHC presentation and T-cell epitopes
34. Abstract B108: Molecular and cellular properties of neoantigen-specific CD8+ T-cells on interaction with B16F10 melanoma in situ
35. Mutation-derived tumor antigens: novel targets in cancer immunotherapy
36. ATIM-31. PHASE I STUDY OF TUMOR TREATMENT FIELDS AND A PERSONALIZED MUTATION-DERIVED TUMOR VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
37. MHCflurry: Open-Source Class I MHC Binding Affinity Prediction
38. Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial
39. Personalized neoantigen vaccination with synthetic long peptides
40. Heterogeneity of mutated tumor antigens in a single high grade ovarian serous carcinoma
41. Computational pipeline for the PGV-001 neoantigen vaccine trial
42. MHCflurry: open-source class I MHC binding affinity prediction
43. Predicting Peptide-MHC Binding Affinities with Imputed Training Data
44. Using a Machine Learning Approach to Predict Outcomes after Radiosurgery for Cerebral Arteriovenous Malformations
45. Patient-Specific Mutation-Derived Tumor Antigens As Targets for Cancer Immunotherapy in Multiple Myeloma
46. A local-view array library for partitioned global address space C++ programs
47. Tracking indoor location and motion for navigational assistance
48. Recognizing currency bills using a mobile phone
49. Parakeet.
50. A local-view array library for partitioned global address space C++ programs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.